CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
about
Ischemic Stroke: Risk Stratification, Warfarin Teatment and Outcome MeasureEffectiveness of integrating delayed computed tomography angiography imaging for left atrial appendage thrombus exclusion into the care of patients undergoing ablation of atrial fibrillationEHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry.Prognostic impact of renal dysfunction in patients with acute coronary syndrome-role beyond the CHA2 DS2 -VASc score: Data from Taiwan acute coronary syndrome full spectrum registry.Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?CHADS2 and CHA2DS2-VASc scoring systems for predicting atrial fibrillation following cardiac valve surgeryYoung Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study.Sequelae after AF ablation: Efficacy and Safety go Hand in HandInteratrial septal thickness as a marker of structural and functional remodeling of the left atrium in patients with atrial fibrillation.Association between CHADS2 score, depressive symptoms, and quality of life in a general population.Stroke in Atrial Fibrillation - Long-term Follow-up of Cardiovascular Events.Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience.CHADS2 score has a better predictive value than CHA2DS2-VASc score in elderly patients with atrial fibrillation.Novel P Wave Indices to Predict Atrial Fibrillation Recurrence After Radiofrequency Ablation for Paroxysmal Atrial FibrillationDiscontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokesRisk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction.Complications From Left Atrial Appendage Exclusion Devices.Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designVenice Chart international consensus document on atrial fibrillation ablation: 2011 update.Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?Catheter ablation of atrial fibrillation to reduce stroke risk.Almanac 2013: cardiac arrhythmias and pacing.Management of atrial fibrillation: What is new in the 2014 ACC/AHA/HRS guideline?2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.Cerebral Embolization During AF Ablation -Pathophysiology, Prevention and Management.Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation.High risk in atrial fibrillation following an ablation procedure: the wide usefulness of the CHADS(2) score.Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.Double-edged blinde, hemorrhagic or cardioembolic cognitive impairment.Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy.Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation.New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery.Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup.Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.Racial disparities in the use of catheter ablation for atrial fibrillation and flutter.Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher.Should We Maintain Anticoagulation after Successful Radiofrequency Catheter Ablation of Atrial Fibrillation? The Need for a Randomized Study.
P2860
Q28075838-D0D0F543-19FE-4A66-A977-DCF249301949Q30278743-6C663727-5B77-4B79-9208-B7926E291EAAQ30375302-AE83E936-D718-46EC-87E3-C01DFFEDACABQ30881747-AF6562F7-7C18-4266-86E9-23912CF3CEBFQ31005750-62F35C96-FE2B-4F21-BC3F-216469BD885BQ33863833-22DF0B7C-794E-42A5-8E84-54954EEDB196Q35062021-96C40F4A-2F78-4576-ABC4-4602AD2B4369Q35303677-51EF9000-F657-4C92-8C38-D8AA25C9025BQ35960738-DE8474B7-85C6-4A3E-9770-012E1EA7B69EQ36124349-A33681D4-F624-4B70-B0A6-0F0C16788ABDQ36272079-58BAFFC2-0AA6-4A60-892E-7C667BF7768EQ36292244-481348E0-4AA6-474A-9404-47A3297AD1DCQ36458873-08C70C19-E593-4935-BB59-0526518744ADQ36773643-64516941-F1DC-4ADA-9304-373564E87029Q37109098-64EB0755-D900-4669-83A8-C17457CF628BQ37130279-D67C34AB-1178-47E6-80C9-EFB436606133Q37301072-B481D7C8-A9B5-491F-880B-8CA636FC1A80Q37468787-B324780C-531D-4838-822F-55DEB0C41D8EQ37468869-A2B992A8-2846-4562-8D4E-C7CBCA27577FQ37672517-BDA6201A-7B38-4ACD-A2CF-254319CE613EQ37989837-D10CF80F-2E42-4959-9318-54A97EB8C0AAQ38041202-F99F1341-5E45-4125-B77D-D141D561AD3AQ38069057-1B9F86D7-ABBF-4F78-BE05-F4CB8EB2A747Q38087518-9C1C1CD3-6DC5-4327-8EE1-17618539AEEBQ38125860-0387583B-094D-4339-85B5-0146079F170EQ38369003-E1DC5EE9-5334-45AE-BD48-29F6D82F7C56Q38647787-99F51070-F4DD-4E37-ACF8-5DC69FFC020FQ38790477-D61801DF-55B9-4A46-9778-B30B079328EFQ39267912-B1D742B4-0E4D-45CF-848C-508969C24425Q39546937-3B054BC3-7D84-4A82-B0CB-8CA17A495B92Q40378922-5DD81D32-63C2-4B84-BC71-C48588A63F14Q41482600-47D11BAA-074F-44EF-9D06-5FFADFE6F3E6Q43737869-BC9EA5D9-0A8C-4BC3-A307-A55120A8BCC9Q44427484-C39E4F01-85A8-4B42-9E62-200684A39E6BQ47099414-F9832856-73A8-4237-91F7-CCECE340428AQ47135508-7E16B095-2456-4F5F-A654-74E9305DC25FQ47921988-99A1D158-7EED-4C2B-8268-AD331F5CB448Q48155306-6CD36E44-A4FC-4FAD-812A-9880A2D9984FQ48570865-40A2DA44-F1D2-4EF2-9BCB-3B6F141B3F06Q49202602-02B280CB-1161-4F7C-B94B-1962BB8E8B90
P2860
CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
CHADS(2) and CHA(2)DS(2)-VASc ...... ation after catheter ablation.
@en
type
label
CHADS(2) and CHA(2)DS(2)-VASc ...... ation after catheter ablation.
@en
prefLabel
CHADS(2) and CHA(2)DS(2)-VASc ...... ation after catheter ablation.
@en
P2093
P1476
CHADS(2) and CHA(2)DS(2)-VASc ...... ation after catheter ablation.
@en
P2093
Beny Hartono
Cheng-Hung Li
Chin-Feng Tsai
Hsuan-Ming Tsao
Hung-Yu Chang
Kazuyoshi Suenari
Kibos Ambrose
Shih-Ann Chen
Shih-Lin Chang
P304
P356
10.1016/J.JACC.2011.08.045
P407
P577
2011-11-01T00:00:00Z